Bender Jeremy
SEC insider (Form 3/4/5 filer). CIK 0001863107. Director at Bicara Therapeutics Inc. (BCAX) and 3 other issuers. 70 reported Form 4/5 transactions since Sep 2024; latest on Jul 28, 2026. Located in BOSTON, MA.
Companies Bender Jeremy has filed insider reports for
- Bicara Therapeutics Inc. (BCAX): Director
- Aura Biosciences, Inc. (AURA): Director
- Day One Biopharmaceuticals, Inc. (DAWN): Director, Officer, CHIEF EXECUTIVE OFFICER
- Mereo BioPharma Group plc (MREO): Director
Bender Jeremy
CIK: 0001863107
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (70 total)
- Jul 28, 2026BCAX
Bicara Therapeutics Inc.
AwardDirectStock Option (Right to Buy)
39K shares- - Jul 7, 2026AURA
Aura Biosciences, Inc.
AwardDirect30K shares- - Apr 23, 2026DAWN
Day One Biopharmaceuticals, Inc.
DispositionIndirect808.3K shares- - Apr 23, 2026DAWN
Day One Biopharmaceuticals, Inc.
DispositionIndirect18.2K shares- - Apr 23, 2026DAWN
Day One Biopharmaceuticals, Inc.
DispositionIndirect147.7K shares- - Apr 23, 2026DAWN
Day One Biopharmaceuticals, Inc.
DispositionIndirect300K shares- - Apr 23, 2026DAWN
Day One Biopharmaceuticals, Inc.
DispositionIndirect20.2K shares- - Apr 23, 2026DAWN
Day One Biopharmaceuticals, Inc.
DispositionIndirect300K shares- - Apr 23, 2026DAWN
Day One Biopharmaceuticals, Inc.
DispositionDirect204.6K shares- - Feb 26, 2026MREO
Mereo BioPharma Group plc
AwardDirectShare Options (Right to buy)
66K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jul 28, 2026 |  BCAX Bicara Therapeutics Inc. | Award Stock Option (Right to Buy) | 38,950 | - | - | Direct |
| Jul 7, 2026 |  AURA Aura Biosciences, Inc. | Award | 30,000 | - | $0 | Direct |
| Apr 23, 2026 |  DAWN Day One Biopharmaceuticals, Inc. | Disposition | 808,285 | - | $0 | Indirect |
| Apr 23, 2026 | DAWN Day One Biopharmaceuticals, Inc. | Disposition | 18,197 | - | $0 | Indirect |
| Apr 23, 2026 | DAWN Day One Biopharmaceuticals, Inc. | Disposition | 147,702 | - | $0 | Indirect |
| Apr 23, 2026 | DAWN Day One Biopharmaceuticals, Inc. | Disposition | 300,000 | - | $0 | Indirect |
| Apr 23, 2026 | DAWN Day One Biopharmaceuticals, Inc. | Disposition | 20,204 | - | $0 | Indirect |
| Apr 23, 2026 | DAWN Day One Biopharmaceuticals, Inc. | Disposition | 300,000 | - | $0 | Indirect |
| Apr 23, 2026 | DAWN Day One Biopharmaceuticals, Inc. | Disposition | 204,643 | - | $0 | Direct |
| Feb 26, 2026 |  MREO Mereo BioPharma Group plc | Award Share Options (Right to buy) | 66,000 | - | - | Direct |
1-10 of 70 transactions